TapewireFind a company

person · Reporting owner

MOORE EDDIE N JR

Disclosed activity across 2 companies

Tapewire entity
140650
SEC CIK
0001114771

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ACCENDRA HEALTH INC/VA/OMI · Entity 6858DirectorMarch 31, 2021April 02, 2021
UNIVERSAL CORP /VA/UVV · Entity 4866DirectorMarch 31, 2020May 15, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ACCENDRA HEALTH INC/VA/

Report date March 31, 2021 · Filed April 02, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible securityDirect28,816 Reported balance After 2021-03-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2021-03-31 · Grant · Acquired 2 · Balance 28,816

F1: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2: Shares acquired through quarterly dividend reinvestment transaction.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2: Shares acquired through quarterly dividend reinvestment transaction.

UNIVERSAL CORP /VA/

Report date March 31, 2020 · Filed May 15, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock - Dividend Reinvestment PlanSEC Table I · non-derivativeDirect5,241 Reported balance Holding disclosure · report date 2020-03-31 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 5,241

F1: Includes 788 shares acquired 4/1/19 through 3/31/20 in the Dividend Reinvestment Plan.

Common StockSEC Table I · non-derivativeDirect22,945 Reported balance Holding disclosure · report date 2020-03-31 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 22,945

F2: Includes 9,650 restricted stock shares granted for service as a director. Also includes 4,700 restricted stock units and 372 dividend equivalent units earned on the restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 788 shares acquired 4/1/19 through 3/31/20 in the Dividend Reinvestment Plan.

F2: Includes 9,650 restricted stock shares granted for service as a director. Also includes 4,700 restricted stock units and 372 dividend equivalent units earned on the restricted stock units.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 31, 2021 Filed Apr 2, 2021 12:28 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 2 $37.59 $75.18
Disclosure

SEC source: 0000075252-21-000063 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,816

Underlying: Common Stock · 2 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
December 31, 2020 Filed Jan 5, 2021 13:26 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 3 $27.05 $81.15
Disclosure

SEC source: 0000075252-21-000004 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,814

Underlying: Common Stock · 3 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
September 30, 2020 Filed Oct 1, 2020 21:41 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 3 $25.11 $75.33
Disclosure

SEC source: 0000075252-20-000126 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,811

Underlying: Common Stock · 3 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
June 30, 2020 Filed Jul 2, 2020 15:57 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 9 $7.62 $68.58
Disclosure

SEC source: 0000075252-20-000093 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,808

Underlying: Common Stock · 9 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
May 11, 2020 Filed May 13, 2020 01:42 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantCommon Stock 17,242 $0.00 $0.00
Disclosure

SEC source: 0000075252-20-000059 · edgar.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,893

F1 · security: Restricted stock with a one year vesting date.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 22:50 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 8 $9.15 $73.20
Disclosure

SEC source: 0000075252-20-000039 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,799

Underlying: Common Stock · 8 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
December 31, 2019 Filed Jan 2, 2020 21:12 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 14 $5.17 $72.38
Disclosure

SEC source: 0000075252-20-000002 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,791

Underlying: Common Stock · 14 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
September 30, 2019 Filed Oct 2, 2019 00:32 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 12 $5.81 $69.72
Disclosure

SEC source: 0000075252-19-000117 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,777

Underlying: Common Stock · 12 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
August 28, 2019 Filed Aug 30, 2019 20:59 UTC UNIVERSAL CORP /VA/ UVV · Entity 4866 GrantCommon Stock 1,650 $0.00 $0.00
Disclosure

SEC source: 0001225385-19-000165 · edgar.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,643

F1 · kind: Award of 1,650 restricted stock units for service as a director. The restricted stock units vest on the first anniversary of the award date.

F2 · balance_after: Includes 9,650 shares of restricted stock, 4,700 restricted stock units and 233 dividend equivalent units earned on the restricted stock units.

F3 · balance_after: Includes shares not previously reported that were acquired through the Dividend Reinvestment Plan.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 20:12 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 22 $3.20 $70.40
Disclosure

SEC source: 0000075252-19-000098 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,765

Underlying: Common Stock · 22 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
May 13, 2019 Filed May 15, 2019 20:50 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantCommon Stock 32,637 $0.00 $0.00
Disclosure

SEC source: 0000075252-19-000083 · edgar.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,651

F1 · security: Restricted stock with a one year vesting date.

F2 · balance_after: Total reflects shares acquired through dividend reinvestment transactions not previously included in beneficial ownership.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 21:01 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 18 $4.10 $73.80
Disclosure

SEC source: 0000075252-19-000059 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,743

Underlying: Common Stock · 18 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
January 02, 2019 Filed Jan 4, 2019 19:37 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 327 $6.51 $2,128.77
Disclosure

SEC source: 0000075252-19-000002 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,725

Underlying: Common Stock · 327 shares

Expires not disclosed

F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
October 01, 2018 Filed Oct 2, 2018 21:27 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 447 $16.26 $7,268.22
Disclosure

SEC source: 0000075252-18-000129 · edgar.xml · derivative · entry 2

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,398

Underlying: Common Stock · 447 shares

Expires not disclosed

F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
September 28, 2018 Filed Oct 2, 2018 21:27 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantCommon Stock 14.018 $16.68 $233.88
Disclosure

SEC source: 0000075252-18-000129 · edgar.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,030.518

F1 · shares: Shares acquired through quarterly dividend reinvestment transaction.

Read SEC document
August 02, 2018 Filed Aug 2, 2018 20:32 UTC UNIVERSAL CORP /VA/ UVV · Entity 4866 GrantCommon Stock 1,500 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-035155 · doc1.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,840

F1 · kind: Award of 1,500 restricted stock units for service as a director. The restricted stock units vest on the third anniversary of the award date; payment, however, will be delayed until certain restrictions are met.

F2 · price: The value of each restricted stock unit ($66.2631) was based upon Bloomberg LLP daily volume weighted average between June 1, 2018 and July 31, 2018.

F3 · balance_after: Includes 9,650 shares of restricted stock, 5,550 restricted stock units and 273 dividend equivalent units earned on the restricted stock units.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 18:22 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 430 $16.63 $7,150.90
Disclosure

SEC source: 0000075252-18-000104 · edgar.xml · derivative · entry 2

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,951

Underlying: Common Stock · 430 shares

Expires not disclosed

F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
June 28, 2018 Filed Jul 3, 2018 18:22 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantCommon Stock 13.5 $17.06 $230.26
Disclosure

SEC source: 0000075252-18-000104 · edgar.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,016.5

F1 · shares: Shares acquired through quarterly dividend reinvestment transaction.

Read SEC document
June 06, 2018 Filed Jun 6, 2018 21:05 UTC UNIVERSAL CORP /VA/ UVV · Entity 4866 SaleCommon Stock 2,000 $65.57 $131,144.00
Disclosure

SEC source: 0001140361-18-027570 · doc1.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,340

F1 · balance_after: 9,650 Restricted stock shares were granted for service as a director. Transfer of shares is prohibited and the shares may be forfeited to the Company unless certain specified conditions are met. Also includes 4,050 restricted stock units and 273 dividend equivalent units earned on the restricted stock units. The restricted stock units vest on the third anniversary of the award date, however, payment will be delayed until certain restrictions are met.

Read SEC document
May 17, 2018 Filed May 18, 2018 16:37 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantCommon Stock 10,355 $0.00 $0.00
Disclosure

SEC source: 0000075252-18-000081 · edgar.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,003

F1 · security: Restricted stock with a one year vesting date.

F2 · balance_after: Total reflects shares acquired through dividend reinvestment transactions not previously included in beneficial ownership.

Read SEC document
March 31, 2018 Filed May 14, 2018 20:15 UTC UNIVERSAL CORP /VA/ UVV · Entity 4866 OtherCommon Stock-Dividend Reinvestment Plan 493 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-18-023332 · doc1.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,813

F1 · price: Shares acquired 4/1/17 through 3/31/18 in the Dividend Reinvestment Plan.

F1 · balance_after: Shares acquired 4/1/17 through 3/31/18 in the Dividend Reinvestment Plan.

Read SEC document
March 30, 2018 Filed Apr 2, 2018 22:23 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 466 $15.09 $7,031.94
Disclosure

SEC source: 0000075252-18-000060 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,521

Underlying: Common Stock · 466 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
December 29, 2017 Filed Jan 2, 2018 15:52 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 364 $18.88 $6,872.32
Disclosure

SEC source: 0000075252-18-000004 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,055

Underlying: Common Stock · 364 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
September 29, 2017 Filed Oct 2, 2017 18:41 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 233 $29.20 $6,803.60
Disclosure

SEC source: 0000075252-17-000117 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,691

Underlying: Common Stock · 233 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
August 03, 2017 Filed Aug 7, 2017 21:20 UTC UNIVERSAL CORP /VA/ UVV · Entity 4866 GrantCommon Stock 1,550 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-030378 · doc1.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,615

F1 · kind: Award of 1,550 restricted stock units for service as a director. The restricted stock units vest on the third anniversary of the award date; payment, however, will be delayed until certain restrictions are met.

F2 · price: The value of each restricted stock unit ($65.0199) was based upon Bloomberg LLP daily volume weighted average between June 1, 2017 and July 31, 2017.

F3 · balance_after: Includes 9,650 shares of restricted stock, 5,350 restricted stock units and 257 dividend equivalent units earned on the restricted stock units.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 16:33 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 210 $32.19 $6,759.90
Disclosure

SEC source: 0000075252-17-000096 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,458

Underlying: Common Stock · 210 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
May 05, 2017 Filed May 8, 2017 20:45 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 3,050 $0.00 $0.00
Disclosure

SEC source: 0000075252-17-000079 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,248

Underlying: Common Stock · 3,050 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
March 31, 2017 Filed Apr 4, 2017 14:39 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 171 $34.60 $5,916.60
Disclosure

SEC source: 0000075252-17-000058 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,198

Underlying: Common Stock · 171 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
March 31, 2017 Filed May 11, 2017 19:19 UTC UNIVERSAL CORP /VA/ UVV · Entity 4866 OtherCommon Stock-Dividend Reinvestment Plan 452 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-17-019697 · doc1.xml · nonDerivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,320

F1 · price: Shares acquired 4/1/16 through 3/31/17 in the Dividend Reinvestment Plan.

F1 · balance_after: Shares acquired 4/1/16 through 3/31/17 in the Dividend Reinvestment Plan.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 14:13 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 165 $35.29 $5,822.85
Disclosure

SEC source: 0000075252-17-000002 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,027

Underlying: Common Stock · 165 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
September 30, 2016 Filed Oct 3, 2016 20:36 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 167 $34.73 $5,799.91
Disclosure

SEC source: 0000075252-16-000213 · edgar.xml · derivative · entry 1

MOORE EDDIE N JR · CIK 0001114771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,862

Underlying: Common Stock · 167 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.